151 related articles for article (PubMed ID: 19538938)
1. CDK11p58 represses vitamin D receptor-mediated transcriptional activation through promoting its ubiquitin-proteasome degradation.
Chi Y; Hong Y; Zong H; Wang Y; Zou W; Yang J; Kong X; Yun X; Gu J
Biochem Biophys Res Commun; 2009 Aug; 386(3):493-8. PubMed ID: 19538938
[TBL] [Abstract][Full Text] [Related]
2. Repression of estrogen receptor alpha by CDK11p58 through promoting its ubiquitin-proteasome degradation.
Wang Y; Zong H; Chi Y; Hong Y; Yang Y; Zou W; Yun X; Gu J
J Biochem; 2009 Mar; 145(3):331-43. PubMed ID: 19122208
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D3 interacts with vitamin D receptor and regulates its transcription activity.
Jian Y; Yan J; Wang H; Chen C; Sun M; Jiang J; Lu J; Yang Y; Gu J
Biochem Biophys Res Commun; 2005 Sep; 335(3):739-48. PubMed ID: 16105657
[TBL] [Abstract][Full Text] [Related]
4. The importance of nuclear import in protection of the vitamin D receptor from polyubiquitination and proteasome-mediated degradation.
Peleg S; Nguyen CV
J Cell Biochem; 2010 Jul; 110(4):926-34. PubMed ID: 20564192
[TBL] [Abstract][Full Text] [Related]
5. CDK11p58 phosphorylation of PAK1 Ser174 promotes DLC2 binding and roles on cell cycle progression.
Kong X; Gan H; Hao Y; Cheng C; Jiang J; Hong Y; Yang J; Zhu H; Chi Y; Yun X; Gu J
J Biochem; 2009 Sep; 146(3):417-27. PubMed ID: 19520772
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic nucleoporin CAN/Nup214 interacts with vitamin D receptor and modulates its function.
Miyauchi Y; Sakaguchi N; Okada T; Makishima M; Ozono K; Michigami T
J Cell Biochem; 2009 Apr; 106(6):1090-101. PubMed ID: 19229862
[TBL] [Abstract][Full Text] [Related]
7. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
8. Cadmium interferes with the degradation of ATF5 via a post-ubiquitination step of the proteasome degradation pathway.
Uekusa H; Namimatsu M; Hiwatashi Y; Akimoto T; Nishida T; Takahashi S; Takahashi Y
Biochem Biophys Res Commun; 2009 Mar; 380(3):673-8. PubMed ID: 19285020
[TBL] [Abstract][Full Text] [Related]
9. PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1.
Nishida T; Terashima M; Fukami K; Yamada Y
Biochem J; 2007 Aug; 405(3):481-8. PubMed ID: 17456046
[TBL] [Abstract][Full Text] [Related]
10. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation.
Maruyama R; Aoki F; Toyota M; Sasaki Y; Akashi H; Mita H; Suzuki H; Akino K; Ohe-Toyota M; Maruyama Y; Tatsumi H; Imai K; Shinomura Y; Tokino T
Cancer Res; 2006 May; 66(9):4574-83. PubMed ID: 16651407
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of beta1,4-galactosyltransferase 1 inhibits CDK11(p58)-mediated apoptosis induced by cycloheximide.
Li Z; Wang H; Zong H; Sun Q; Kong X; Jiang J; Gu J
Biochem Biophys Res Commun; 2005 Feb; 327(2):628-36. PubMed ID: 15629159
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of CDK11p58 and cyclin D3 following spinal cord injury in rats.
Ji Y; Xiao F; Sun L; Qin J; Shi S; Yang J; Liu Y; Zhou D; Zhao J; Shen A
Mol Cell Biochem; 2008 Feb; 309(1-2):49-60. PubMed ID: 18008145
[TBL] [Abstract][Full Text] [Related]
13. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.
Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
[TBL] [Abstract][Full Text] [Related]
14. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
González-Avión XC; Mouriño A; Rochel N; Moras D
J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Vitamin D receptor in the intestinal induction of human ABCB1.
Tachibana S; Yoshinari K; Chikada T; Toriyabe T; Nagata K; Yamazoe Y
Drug Metab Dispos; 2009 Aug; 37(8):1604-10. PubMed ID: 19460946
[TBL] [Abstract][Full Text] [Related]
16. The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation.
Salehi-Tabar R; Memari B; Wong H; Dimitrov V; Rochel N; White JH
Mol Cancer Res; 2019 Mar; 17(3):709-719. PubMed ID: 30606768
[TBL] [Abstract][Full Text] [Related]
17. The hinge region of the androgen receptor plays a role in proteasome-mediated transcriptional activation.
Tanner T; Claessens F; Haelens A
Ann N Y Acad Sci; 2004 Dec; 1030():587-92. PubMed ID: 15659841
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle-dependent PC-PLC regulation by APC/C(Cdc20)-mediated ubiquitin-proteasome pathway.
Fu D; Ma Y; Wu W; Zhu X; Jia C; Zhao Q; Zhang C; Wu XZ
J Cell Biochem; 2009 Jul; 107(4):686-96. PubMed ID: 19347873
[TBL] [Abstract][Full Text] [Related]
19. Are vitamin D receptor activators useful for the treatment of thrombosis?
Wu-Wong JR
Curr Opin Investig Drugs; 2009 Sep; 10(9):919-27. PubMed ID: 19705334
[TBL] [Abstract][Full Text] [Related]
20. RACK1 associates with CLEC-2 and promotes its ubiquitin-proteasome degradation.
Ruan Y; Guo L; Qiao Y; Hong Y; Zhou L; Sun L; Wang L; Zhu H; Wang L; Yun X; Xie J; Gu J
Biochem Biophys Res Commun; 2009 Dec; 390(2):217-22. PubMed ID: 19785988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
